Multiple Myeloma

Novartis bone marrow cancer drug meets goal in late-stage study
Yahoo/AP
Fri, 12/6/13 - 09:01 am
Novartis
LBH589
Multiple Myeloma
Celgene's Revlimid Faces a Tough Sell
Motley Fool
Tue, 11/19/13 - 07:25 am
Celgene
Revlimid
JNJ
Multiple Myeloma
Has Myeloma Met Its Match in Amgen's Kyprolis?
Motley Fool
Mon, 11/18/13 - 11:07 am
Multiple Myeloma
Amgen
Kyprolis
Celgene
Celgene's Revlimid Makes Stronger Case for European Front-Line Approval
TheStreet.com
Wed, 11/13/13 - 11:00 am
Celgene
Revlimid
Europe
Multiple Myeloma
J&J's Velcade gets stiff-armed at NICE as first-line myeloma treatment
Fierce Pharma
Tue, 11/12/13 - 04:37 pm
JNJ
Velcade
Multiple Myeloma
Array Biopharma Outlines Path To Market For New Myeloma Drug
Forbes
Thu, 10/31/13 - 08:56 am
Multiple Myeloma
Array Biopharma
ARRY-520
Kyprolis
Celgene's New Multiple Myeloma Drug Is Beating Amgen
TheStreet.com
Thu, 10/24/13 - 09:59 am
Celgene
Multiple Myeloma
Amgen
Kyprolis
Pomalyst
Celgene says phase III study of pomalidomide combo met primary endpoint
Yahoo/Fly on the Wall
Thu, 09/5/13 - 08:26 am
Celgene
pomalidomide
Multiple Myeloma
Celgene's Multiple Myeloma Powerhouse
Motley Fool
Thu, 08/22/13 - 11:21 am
Multiple Myeloma
Celgene
Thalomid
Revlimid
Pomalyst
Celgene spends $100M for option to buy myeloma drug developer Acetylon
Fierce Biotech
Mon, 07/29/13 - 01:36 pm
Celgene
Multiple Myeloma
M&A
Acetylon
Celgene's Revlimid improves survival in blood cancer patients
Reuters
Thu, 07/11/13 - 11:14 am
Celgene
Revlimid
Multiple Myeloma
Coronado Biosciences Reuniting Old Friends
Seeking Alpha
Fri, 07/5/13 - 10:40 am
Coronado Biosciences
CNDO-201
CNDO-109
Crohn's Disease
Multiple Myeloma
acute myeloid leukemia
MorphoSys Rises on $818 Million Drug Alliance
Bloomberg
Thu, 06/27/13 - 10:41 am
MorphoSys
MOR202
Celgene
Multiple Myeloma
Johnson & Johnson's Potential Blockbuster For Multiple Myeloma And Its Competitors
Seeking Alpha
Tue, 06/4/13 - 09:36 am
JNJ
Multiple Myeloma
daratumumab
Genmab
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Yahoo/MarketWire
Sun, 06/2/13 - 11:39 am
Threshold Pharmaceuticals
TH-302
Multiple Myeloma
gastrointestinal stromal tumors
renal cell carcinoma
kidney cancer
Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Bloomberg
Thu, 05/2/13 - 10:31 am
Genmab
FDA
JNJ
daratumumab
Multiple Myeloma
Celgene's Star Drug Revlimid And Its Competitors
Seeking Alpha
Sat, 03/30/13 - 10:57 am
Celgene
Revlimid
Multiple Myeloma
JNJ
Velcade
AbbVie
Bristol-Myers Squibb
elotuzumab
Genmab Rises as Nordea Says Bet on Cancer Drug: Copenhagen Mover
Bloomberg
Wed, 03/20/13 - 12:09 pm
Genmab
JNJ
daratumumab
Multiple Myeloma
Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation
Yahoo
Mon, 03/11/13 - 12:33 pm
Aeterna Zentaris
Multiple Myeloma
perifosine
Celgene And The Race To Cure Multiple Myeloma
Seeking Alpha
Sat, 02/16/13 - 11:23 am
Celgene
Multiple Myeloma
Pomalyst

Pages